Vitas Pharma

Indian, preclinical stage biopharma developing small molecule therapeutics for MDR bacterial infections (ESKAPE pathogens)

placeHyderabad, Telangana, India calendar_todayFounded 2010 groups6 employees language vitaspharma.com

Registered entities

Investor mix

47 investors on record; lead investors include Array.

Investor typeCountShare
Venture capital12%
Angel & family office24%
Accelerator & incubator24%
Bank & private debt12%
Other / undisclosed4187%
Coming soon